DRC mpox cases decrease by 50% by end of 2025?

LC16m8 mpox vaccine US approval by December 31, 2025?

DRC to receive pledged mpox vaccines from Japan by Dec 31, 2024?

Mpox cases in DRC to exceed 30,000 by Dec 31, 2024?

Next company to receive WHO emergency use listing for mpox vaccine?

Japan donates additional 2M LC16m8 doses to Africa by end of 2025?

Will Japan donate 3M doses of LC16m8 vaccine to DRC by end of 2024?

Will DRC start administering LC16m8 vaccine by March 2025?

Will Emergent BioSolutions receive FDA approval for the supplemental Biologics License Application for Ebanga™ by September 30, 2025?

Will Emergent BioSolutions submit a supplemental Biologics License Application for Ebanga™ by December 31, 2024?

Percentage change in Emergent BioSolutions' stock by end of 2024?

Will Emergent BioSolutions' stock increase by 10% or more by September 2024?

Region receiving most LC16m8 mpox vaccine donations by end of 2025?

Age group with most significant mpox case reduction in DRC by end of 2025?

Japan's KM Biologics to deliver 3M LC16m8 mpox doses to DRC by June 30, 2025?

Next country to approve LC16m8 mpox vaccine for emergency use by end of 2025?

Largest additional funding source for Mpox vaccination in Africa by June 2025?

LC16m8 mpox vaccine distributed to 5+ African countries by June 2025?

DRC reports 50% reduction in Mpox cases among children under 5 by end of 2025?

Percentage reduction in Mpox mortality rate in DRC under 5 by end of 2025?

Will LC16m8 receive additional emergency use authorizations by mid-2025?

Which country will primarily receive Japan's LC16m8 vaccine donation by mid-2025?

Which region will receive significant LC16m8 vaccine donations after DRC by end of 2025?

Which age group will be primarily targeted for LC16m8 vaccine in DRC by end of 2024?

Will Emergent BioSolutions complete scale-up process validation for Ebanga™ by March 31, 2025?

What will be the status of Emergent BioSolutions' post-licensure commitments for Ebanga™ by December 31, 2025?

What will be the status of Emergent BioSolutions' technology transfer for Ebanga™ by June 30, 2025?

What will be the status of Emergent BioSolutions' commercial readiness for Ebanga™ by December 31, 2024?

WHO to approve additional mpox diagnostic test by Dec 31, 2024?

African country with highest mpox cases by Dec 31, 2024?

Entity securing most mpox vaccines through UNICEF tender by Dec 31, 2024?

First country to report 50% decrease in mpox cases by Dec 31, 2024?

Will U.S. mpox cases decrease by 50% or more by the end of 2024?

Region with highest new mpox cases by end of 2024?

Will another mpox-related vaccine be FDA-approved by the end of 2024?

Market share of ACAM2000 in mpox vaccine market by end of 2024?